STAT4h
Pharmalittle: We’re reading about the RFK Jr. confirmation hearings, CMS plans for drug-pricing talks, and more
In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...
STAT1d
Pharmalittle: We’re reading about a Super Bowl ad for compounded obesity drugs, a PEPFAR waiver, and more
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider
Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.